ResearcherUniversity of IowaNo recent work listed
Justin G. Wilkes
Matched on ORCID iD 0000-0002-8080-8450; OpenAlex author ID A5009200111. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2017: 1 paper · 2018: 2 papers · 2019: 1 paper
Papers 4
- Enhanced Pharmacological Ascorbate Oxidation Radiosensitizes Pancreatic Cancer. Co-author DOI 10.1667/rr15189.1↗
- Pharmacologic ascorbate (P-AscH-) suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic adenocarcinoma. Co-author DOI 10.1007/s10585-018-9876-z↗
- Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancreatic Cancer. First author DOI 10.1158/0008-5472.can-18-1680↗
- Superoxide Dismutases in Pancreatic Cancer. Co-author DOI 10.3390/antiox6030066↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Matthew S. Alexander · 4 shared papers, 2017–2019 · strength 0.35
- Paper Superoxide Dismutases in Pancreatic Cancer. DOI 10.3390/antiox6030066↗
- Paper Enhanced Pharmacological Ascorbate Oxidation Radiosensitizes Pancreatic Cancer. DOI 10.1667/rr15189.1↗
- Paper Pharmacologic ascorbate (P-AscH-) suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic adenocarcinoma. DOI 10.1007/s10585-018-9876-z↗
- Joseph J. Cullen · 4 shared papers, 2017–2019 · strength 0.35
- Paper Superoxide Dismutases in Pancreatic Cancer. DOI 10.3390/antiox6030066↗
- Paper Enhanced Pharmacological Ascorbate Oxidation Radiosensitizes Pancreatic Cancer. DOI 10.1667/rr15189.1↗
- Paper Pharmacologic ascorbate (P-AscH-) suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic adenocarcinoma. DOI 10.1007/s10585-018-9876-z↗
- Brianne R. O’Leary · 3 shared papers, 2018–2019 · strength 0.24
- Paper Enhanced Pharmacological Ascorbate Oxidation Radiosensitizes Pancreatic Cancer. DOI 10.1667/rr15189.1↗
- Paper Pharmacologic ascorbate (P-AscH-) suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic adenocarcinoma. DOI 10.1007/s10585-018-9876-z↗
- Paper Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancr… DOI 10.1158/0008-5472.can-18-1680↗
- Garry R. Buettner · 3 shared papers, 2018–2019 · strength 0.24
- Paper Enhanced Pharmacological Ascorbate Oxidation Radiosensitizes Pancreatic Cancer. DOI 10.1667/rr15189.1↗
- Paper Pharmacologic ascorbate (P-AscH-) suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic adenocarcinoma. DOI 10.1007/s10585-018-9876-z↗
- Paper Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancr… DOI 10.1158/0008-5472.can-18-1680↗
- Juan Du · 3 shared papers, 2018–2019 · strength 0.24
- Paper Enhanced Pharmacological Ascorbate Oxidation Radiosensitizes Pancreatic Cancer. DOI 10.1667/rr15189.1↗
- Paper Pharmacologic ascorbate (P-AscH-) suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic adenocarcinoma. DOI 10.1007/s10585-018-9876-z↗
- Paper Pharmacologic Ascorbate Reduces Radiation-Induced Normal Tissue Toxicity and Enhances Tumor Radiosensitization in Pancr… DOI 10.1158/0008-5472.can-18-1680↗
- Rosa F. Hwang · 1 shared paper, 2019 · strength 0.09
- Ehab H. Sarsour · 1 shared paper, 2019 · strength 0.09
- Zita A. Sibenaller · 1 shared paper, 2018 · strength 0.08
- Susan Tsai · 1 shared paper, 2018 · strength 0.08
- Douglas Robert Spitz · 1 shared paper, 2018 · strength 0.07
- Daniel Berg · 1 shared paper, 2018 · strength 0.07
- John Michael Buatti · 1 shared paper, 2018 · strength 0.07
- Bryan G. Allen · 1 shared paper, 2018 · strength 0.07
- Kellie L. Bodeker · 1 shared paper, 2018 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.